Cargando…

Neutral lipids as early biomarkers of cellular fate: the case of α-synuclein overexpression

α-synuclein (α-syn) accumulation and aggregation is a common pathological factor found in synucleinopathies, a group of neurodegenerative disorders that includes Parkinson´s disease (PD). It has been proposed that lipid dyshomeostasis is responsible for the occurrence of PD-related processes, howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Alza, Natalia P., Conde, Melisa A., Scodelaro-Bilbao, Paola G., Salvador, Gabriela A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791139/
https://www.ncbi.nlm.nih.gov/pubmed/33414430
http://dx.doi.org/10.1038/s41419-020-03254-7
_version_ 1783633547084431360
author Alza, Natalia P.
Conde, Melisa A.
Scodelaro-Bilbao, Paola G.
Salvador, Gabriela A.
author_facet Alza, Natalia P.
Conde, Melisa A.
Scodelaro-Bilbao, Paola G.
Salvador, Gabriela A.
author_sort Alza, Natalia P.
collection PubMed
description α-synuclein (α-syn) accumulation and aggregation is a common pathological factor found in synucleinopathies, a group of neurodegenerative disorders that includes Parkinson´s disease (PD). It has been proposed that lipid dyshomeostasis is responsible for the occurrence of PD-related processes, however, the precise role of lipids in the onset and progression of neurodegenerative disorders remains unclear. Our aim was to investigate the effect of α-syn overexpression on neutral lipid metabolism and how this impacts on neuronal fate. We found lipid droplet (LD) accumulation in cells overexpressing α-syn to be associated with a rise in triacylglycerol (TAG) and cholesteryl ester (CE) levels. α-syn overexpression promoted diacylglycerol acyltransferase 2 upregulation and acyl-CoA synthetase activation, triggering TAG buildup, that was accompanied by an increase in diacylglycerol acylation. Moreover, the CE increment was associated with higher activity of acyl-CoA:cholesterol acyltransferase. Interestingly, α-syn overexpression increased cholesterol lysosomal accumulation. We observed that sterol regulatory element-binding protein (SREBP)-1 and SREBP-2 were differentially regulated by α-syn overexpression. The latter gave rise to a reduction in SREBP-1 nuclear translocation and consequently in fatty acid synthase expression, whereas it produced an increase in SREBP-2 nuclear localization. Surprisingly, and despite increased cholesterol levels, SREBP-2 downstream genes related to cholesterolgenesis were not upregulated as expected. Notably, phospholipid (PL) levels were diminished in cells overexpressing α-syn. This decrease was related to the activation of phospholipase A2 (PLA2) with a concomitant imbalance of the PL deacylation-acylation cycle. Fatty acids released from PLs by iPLA2 and cPLA2 action were esterified into TAGs, thus promoting a biological response to α-syn overexpression with uncompromised cell viability. When the described steady-state was disturbed under conditions favoring higher levels of α-syn, the response was an enhanced LD accumulation, this imbalance ultimately leading to neuronal death.
format Online
Article
Text
id pubmed-7791139
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-77911392021-01-15 Neutral lipids as early biomarkers of cellular fate: the case of α-synuclein overexpression Alza, Natalia P. Conde, Melisa A. Scodelaro-Bilbao, Paola G. Salvador, Gabriela A. Cell Death Dis Article α-synuclein (α-syn) accumulation and aggregation is a common pathological factor found in synucleinopathies, a group of neurodegenerative disorders that includes Parkinson´s disease (PD). It has been proposed that lipid dyshomeostasis is responsible for the occurrence of PD-related processes, however, the precise role of lipids in the onset and progression of neurodegenerative disorders remains unclear. Our aim was to investigate the effect of α-syn overexpression on neutral lipid metabolism and how this impacts on neuronal fate. We found lipid droplet (LD) accumulation in cells overexpressing α-syn to be associated with a rise in triacylglycerol (TAG) and cholesteryl ester (CE) levels. α-syn overexpression promoted diacylglycerol acyltransferase 2 upregulation and acyl-CoA synthetase activation, triggering TAG buildup, that was accompanied by an increase in diacylglycerol acylation. Moreover, the CE increment was associated with higher activity of acyl-CoA:cholesterol acyltransferase. Interestingly, α-syn overexpression increased cholesterol lysosomal accumulation. We observed that sterol regulatory element-binding protein (SREBP)-1 and SREBP-2 were differentially regulated by α-syn overexpression. The latter gave rise to a reduction in SREBP-1 nuclear translocation and consequently in fatty acid synthase expression, whereas it produced an increase in SREBP-2 nuclear localization. Surprisingly, and despite increased cholesterol levels, SREBP-2 downstream genes related to cholesterolgenesis were not upregulated as expected. Notably, phospholipid (PL) levels were diminished in cells overexpressing α-syn. This decrease was related to the activation of phospholipase A2 (PLA2) with a concomitant imbalance of the PL deacylation-acylation cycle. Fatty acids released from PLs by iPLA2 and cPLA2 action were esterified into TAGs, thus promoting a biological response to α-syn overexpression with uncompromised cell viability. When the described steady-state was disturbed under conditions favoring higher levels of α-syn, the response was an enhanced LD accumulation, this imbalance ultimately leading to neuronal death. Nature Publishing Group UK 2021-01-07 /pmc/articles/PMC7791139/ /pubmed/33414430 http://dx.doi.org/10.1038/s41419-020-03254-7 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Alza, Natalia P.
Conde, Melisa A.
Scodelaro-Bilbao, Paola G.
Salvador, Gabriela A.
Neutral lipids as early biomarkers of cellular fate: the case of α-synuclein overexpression
title Neutral lipids as early biomarkers of cellular fate: the case of α-synuclein overexpression
title_full Neutral lipids as early biomarkers of cellular fate: the case of α-synuclein overexpression
title_fullStr Neutral lipids as early biomarkers of cellular fate: the case of α-synuclein overexpression
title_full_unstemmed Neutral lipids as early biomarkers of cellular fate: the case of α-synuclein overexpression
title_short Neutral lipids as early biomarkers of cellular fate: the case of α-synuclein overexpression
title_sort neutral lipids as early biomarkers of cellular fate: the case of α-synuclein overexpression
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791139/
https://www.ncbi.nlm.nih.gov/pubmed/33414430
http://dx.doi.org/10.1038/s41419-020-03254-7
work_keys_str_mv AT alzanataliap neutrallipidsasearlybiomarkersofcellularfatethecaseofasynucleinoverexpression
AT condemelisaa neutrallipidsasearlybiomarkersofcellularfatethecaseofasynucleinoverexpression
AT scodelarobilbaopaolag neutrallipidsasearlybiomarkersofcellularfatethecaseofasynucleinoverexpression
AT salvadorgabrielaa neutrallipidsasearlybiomarkersofcellularfatethecaseofasynucleinoverexpression